Stocks / NASDAQ / Pliant Therapeutics Inc.

Pliant Therapeutics Inc.

Our Opinion

Pliant Therapeutics Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of its medical analysis and clinical research.

Supporting Evidence:

The company mentioned on its website that they use animals for product testing.

“Our product candidates have shown anti-fibrotic activity in multiple animal models as well as live human tissues in indications outside of IPF, PSC, and NASH.” Read the following article

Company Description

Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. Pliant Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Company Website: